A detailed history of Rothschild Investment LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 50 shares of EOLS stock, worth $641. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 20 150.0%
Holding current value
$641
Previous $217,000 273.27%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$10.66 - $17.48 $319 - $524
30 Added 150.0%
50 $810,000
Q2 2024

Jul 30, 2024

BUY
$10.45 - $13.76 $209 - $275
20 New
20 $217,000
Q1 2024

Jul 31, 2024

SELL
$9.99 - $14.91 $99 - $149
-10 Reduced 50.0%
10 $140,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $720M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.